Home » Topics » BioWorld Science

BioWorld Science
RSS

Phenanthroline derivative with antitumor activity in liver cancer models

March 4, 2022

Targeting alpha2-Na+/K+ ATPase improves tau pathology in vivo

March 4, 2022

Cornell University patents PROTACs targeting BET domain proteins

March 4, 2022

New mucolipin-1 agonists divulged by Casma Therapeutics

March 4, 2022

New prodrugs of PIN1 inhibitors discovered at the University of California

March 4, 2022

Abm Therapeutics identifies new AXL/PAK1/c-KIT/RET/MAP4K1 inhibitors

March 4, 2022

Clarity Pharmaceuticals describes new radiopharmaceuticals

March 4, 2022

Researchers present new murine model of aeroallergen-induced EoE

March 4, 2022

Infection in thymus causes autoimmunity in stomach

March 3, 2022

Intranasal COVID-19 booster BW-1019 provides protection and boosts immune response in hamsters

March 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...